Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.3.2024Zentiva, k.s. (ZNT-1)87906Korylan (tbl 10x325 mg/28,73 mg (blis.PVC/Al))21.3.2024O
 20.3.2024MEDOCHEMIE Ltd. (MOE)3671CMEDOCLAV 400 mg/5 ml + 57 mg/5 ml prášok na perorálnu suspenziu (plu por 1x70 ml (fľ.skl.hnedá+dáv.striek.))18.3.2024O
 20.3.2024MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))18.3.2024O
 20.3.2024MEDOCHEMIE Ltd. (MOE)46239MEDOTRIGIN 50 mg (tbl 30x50 mg (blis.PVC/Al))18.3.2024R
 20.3.2024MEDOCHEMIE Ltd. (MOE)59193BETAC (tbl flm 100x20 mg (blister PVC/Al))18.3.2024R
 20.3.2024MEDOCHEMIE Ltd. (MOE)67520MEDOCIPRIN 500 mg (tbl flm 10x500 mg (blis.PVC/Al))18.3.2024R
 20.3.2024MEDOCHEMIE Ltd. (MOE)67569MABRON 50 mg (cps dur 20x50 mg (blis.Al/PVC))18.3.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)23887Paracetamol Kabi 10 mg/ml (sol inf 10x100 ml/1000 mg (liek.inj.skl.))15.4.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)5281CSmofKabiven extra Nitrogen (emu inf 4x1518 ml (vak Biofin))1.4.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)10086Neodolpasse (sol inf 10x250 ml (fľ.skl.))25.3.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)5868DIbuprofen Kabi 400 mg (sol inf 40x400 mg/100 ml (fľ.LDPE))21.3.2024R
 20.3.2024Fresenius Kabi s.r.o. (FRK-CZ-3)58629NUTRAMIN VLI (sol inf 10x500 ml (fľ.skl.inf.))20.3.2024O
 20.3.2024Viatris Limited (VIM)5804CSeizpat 150 mg (tbl flm 56x150 mg (blis.PVC/PVDC/Al))20.3.2024O
 20.3.2024Viatris Limited (VIM)5815CSeizpat 200 mg (tbl flm 56x200 mg (blis.PVC/PVDC/Al))20.3.2024O
 20.3.2024Exeltis Slovakia s.r.o. (EET)1560DEndovelle 2 mg tablety (tbl 1x28x2 mg (blis.Al/PVC/PVDC-kalendár.bal.))20.3.2024Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)